Lars Lange Selected Research

4'-N,N-dimethylamino-4-aminoazobenzene

1/2021	Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).
1/2015	Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (Æ-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF).
1/2014	Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Lange Research Topics

Disease

13	Hypersensitivity (Allergy) 01/2022 - 01/2014
13	Anaphylaxis (Anaphylactic Shock) 01/2021 - 09/2011
6	Food Hypersensitivity (Food Allergy) 01/2022 - 01/2015
3	Asthma (Bronchial Asthma) 01/2021 - 01/2014
3	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 12/2019
1	Disease Progression 01/2022
1	Enterocolitis 01/2022
1	Chronic Urticaria 11/2020
1	Celiac Disease (Celiac Sprue) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2015
1	Protein C Deficiency 07/2015
1	Metabolic Diseases (Metabolic Disease) 01/2015
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2014
1	Exanthema (Rash) 05/2012
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2009
1	Whooping Cough (Pertussis) 03/2008

Drug/Important Bio-Agent (IBA)

7	Immunoglobulin E (IgE)IBA 01/2022 - 01/2014
7	AllergensIBA 01/2022 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 11/2018
4	Pharmaceutical PreparationsIBA 11/2018 - 05/2012
3	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	hypoxanthine arabinoside (ara-H)IBA 01/2016 - 01/2014
1	oligofructoseIBA 01/2022
1	PrebioticsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	OligosaccharidesIBA 01/2022
1	Inulin FDA Link 01/2022
1	Histamine Antagonists (Antihistamines)IBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 11/2020
1	Glutens (Glutelin)IBA 01/2018
1	Arthropod VenomsIBA 04/2016
1	Protein CIBA 07/2015
1	Surface-Active Agents (Surfactants)IBA 07/2015
1	N,N- dimethylcarbamoyl- 4- (4- guanidinobenzyloxy)phenyl acetate methane sulfateIBA 01/2014
1	CarbohydratesIBA 01/2014
1	Profilins (Profilin)IBA 01/2014
1	AntigensIBA 01/2009
1	dornase alfa (Pulmozyme)FDA Link 03/2008

Therapy/Procedure

3	Emergency Treatment 01/2021 - 04/2016
3	Therapeutics 01/2021 - 01/2014
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Immunotherapy 10/2020 - 12/2019
1	Self Administration (Administration, Self) 01/2021
1	Secondary Prevention 01/2020
1	Gluten-Free Diet 01/2018
1	Diet Therapy (Therapy, Diet) 01/2014